Seeking Alpha

SRNE
  Sorrento Therapeutics, Inc. - NASDAQ

11/24/2014, 3:26 PM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
SRNE vs. ETF Alternatives
Company Description
Sorrento Therapeutics, Inc., discovers and develops human therapeutic antibodies for the treatment of cancer, inflammation, metabolic and infectious diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States